Drugs / Lentiviral vector transduced CD34+ cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05207657 | Mar 2023 → Apr 2029 expected | immune deficiency due to impaired neutrophil phagocytosis and migration | Great Ormond Street Hospital for Children NHS Foundation Trust | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lentiviral vector transduced CD34+ cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05207657 ↗ |